Artivion (AORT) Research & Development (2010 - 2026)
Artivion (AORT) posted Research & Development of $8.8 million for Q1 2026, down 3.08% on a QoQ basis from $9.1 million in Q4 2025, and up 31.41% year-over-year from $6.7 million in Q1 2025.
Artivion (AORT) Research & Development (2010 - 2026) Analysis & Trends
Artivion's Research & Development history runs 17 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- Quarterly Research & Development rose 31.41% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.1 million (up 17.25% YoY) and the FY2025 annual result came in at $31.0 million, up 8.92% from the prior year.
- Research & Development was $8.8 million for Q1 2026 at Artivion, down from $9.1 million in the prior quarter.
- Across five years, Research & Development topped out at $11.8 million in Q3 2022 and bottomed at $6.4 million in Q3 2023.
- A 5-year average of $8.0 million and a median of $7.5 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development sank 45.58% — and 2026, when it jumped 31.41%.
- Artivion's Research & Development stood at $8.3 million in 2022, then retreated by 7.94% to $7.6 million in 2023, then decreased by 3.15% to $7.4 million in 2024, then rose by 23.2% to $9.1 million in 2025, then declined by 3.08% to $8.8 million in 2026.
- Business Quant data shows AORT's Research & Development at $8.8 million in Q1 2026, $9.1 million in Q4 2025, and $8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 8.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.84 Mn |
| Dec 31, 2025 | 9.12 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 6.73 Mn |
| Dec 31, 2024 | 7.40 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 6.95 Mn |
| Dec 31, 2023 | 7.65 Mn |
| Sep 30, 2023 | 6.42 Mn |
| Jun 30, 2023 | 7.42 Mn |
| Mar 31, 2023 | 7.22 Mn |
| Dec 31, 2022 | 8.30 Mn |
| Sep 30, 2022 | 11.80 Mn |
| Jun 30, 2022 | 8.65 Mn |
| Mar 31, 2022 | 10.13 Mn |
| Dec 31, 2021 | 9.46 Mn |
| Sep 30, 2021 | 9.97 Mn |
| Jun 30, 2021 | 8.36 Mn |